Monthly Vaccine Preventable Disease and Immunization Update Published: March 10, 2015 Immunization and Vaccine Development (IVD) SEARO

Size: px
Start display at page:

Download "Monthly Vaccine Preventable Disease and Immunization Update Published: March 10, 2015 Immunization and Vaccine Development (IVD) SEARO"

Transcription

1 Monthly Vaccine Preventable Disease and Immunization Update Published: March 10, 2015 Immunization and Vaccine Development (IVD) SEARO Protecting People from Vaccine Preventable Diseases

2 Last wild poliovirus case by type, SEAR WPV Type 2 District: Aligarh State: Uttar Pradesh (India) Date of onset: 24-Oct-1999 WPV Type 3 District: Pakur State: Jharkhand (India) Date of onset: 22-Oct-2010 WPV Type 1 District: Howrah State: West Bengal (India) Date of onset: 13-Jan-2011 Last wild poliovirus case by country Country Year Bangladesh 2006 Bhutan 1986 DPR Korea 1996 India 2011 Indonesia 2006 Maldives 1994 Myanmar 2007 Nepal 2010 Sri Lanka 1993 Thailand 1997 Timor-Leste 1995 *Dots are randomly placed within blocks (Sub-districts)

3 Non-Polio AFP Rate Non-polio AFP Rate* SEAR, and above ~~~~~~~~ SEAR Minimum Target 0 BAN BHU DPRK IND INO MAV MMR NEP SRL THA TLS * Number of discarded AFP cases per 100,000 children under 15 years of age 3

4 Percent Percent Adequate Stool Specimen Collection* SEAR, Minimum Target BAN BHU DPRK IND INO MAV MMR NEP SRL THA TLS *Percentage with 2 specimens 24 hours apart and within 14 days of paralysis onset. 4

5 N=847 N=909 N=862 Percent of Non-Polio AFP Cases Under Immunized for OPV (6 Months to 5 Yrs), SEAR, N=794 N=832 N=33081 N=35175 N=33691 N=30571 N=28206 N=762 N=931 N=987 N=964 N=827 N=137 N=170 N=164 N=145 N=157 N=281 N=277 N=303 N=291 N=236 N=98 N=103 N=100 N=76 N=77 5

6 Non-polio AFP Rate* Surveillance Indicators by District India, 2014 Percent Adequate Stool Specimen Collection ** Non-Polio AFP Rate < >2 No Non-Polio AFP Case Adequate Stool Specimen Collection < 60% 60% 79% > 80% No AFP Case * Number of discarded AFP cases per 100,000 children under 15 years of age ** Percentage with 2 specimens 24 hours apart and within 14 days of paralysis onset. Note: Some AFP cases may still be pending final classification. Total AFP Cases = Non-Polio AFP Rate =12.07 Adequate Stool specimen = 86% Districts reporting AFP cases= 636 (95%) 6

7 Non-polio AFP Cases by Month of Onset India, Month Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec Total

8 Surveillance Indicators by District Nepal, 2014 Non-polio AFP Rate* Percent Adequate Stool Specimen Collection ** Non-Polio AFP Rate < >2 No Non-Polio AFP Case Total AFP Cases = 486 Non-Polio AFP Rate = 4.82 Adequate Stool specimen = 95% Districts reporting AFP cases= 70 (93%) Adequate Stool Specimen Collection < 60% 60% 79% > 80% No AFP Case * Number of discarded AFP cases per 100,000 children under 15 years of age ** Percentage with 2 specimens 24 hours apart and within 14 days of paralysis onset. Note: Some AFP cases may still be pending final classification. 8

9 Non-polio AFP Cases by Month of Onset Month Nepal, Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec Total

10 Non-polio AFP Rate* Surveillance Indicators by Province Myanmar, 2014 Percent Adequate Stool Specimen Collection ** Non-Polio AFP Rate < >2 No Non-Polio AFP Case Adequate Stool Specimen Collection < 60% 60% 79% > 80% No AFP Case * Number of discarded AFP cases per 100,000 children under 15 years of age. ** Percentage with 2 specimens 24 hours apart and within 14 days of paralysis onset. Note: Some AFP cases may still be pending final classification. Total AFP Cases = 390 Non-Polio AFP Rate =1.78 Adequate Stool specimen = 96% Provinces reporting AFP cases= 18 (100%) 10

11 Non-polio AFP Cases by Month of Onset Myanmar, Month Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec Total

12 Surveillance Indicators by District Bangladesh, 2014 Non-polio AFP Rate* Percent Adequate Stool Specimen Collection ** Non-Polio AFP Rate < >2 No Non-Polio AFP Case * Number of discarded AFP cases per 100,000 children under 15 years of age. ** Percentage with 2 specimens 24 hours apart and within 14 days of paralysis onset. Note: Some AFP cases may still be pending final classification. Total AFP Cases = 1477 Non-Polio AFP Rate =2.72 Adequate Stool specimen = 98% Districts reporting AFP cases= 64 (100%) Adequate Stool Specimen Collection < 60% 60% 79% > 80% No AFP Case 12

13 Non-polio AFP Cases by Month of Onset Bangladesh, Month Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec Total

14 Non-polio AFP Rate* Surveillance Indicators by Province Indonesia, 2014 Non-Polio AFP Rate < >2 No Non-Polio AFP Case Percent Adequate Stool Specimen Collection ** Total AFP Cases = 1732 Non-Polio AFP Rate = 2.25 Adequate Stool specimen = 90% Provinces reporting AFP cases= 34 (100%) Adequate Stool Specimen Collection < 60% 60% 79% > 80% No AFP Case * Number of discarded AFP cases per 100,000 children under 15 years of age ** Percentage with 2 specimens 24 hours apart and within 14 days of paralysis onset. Note: Some AFP cases may still be pending final classification. 14

15 Non-polio AFP Cases by Month of Onset Indonesia, Month Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec Total

16 Annualized Non-polio AFP Rate* Surveillance Indicators by Province Thailand, 2014 Percent Adequate Stool Specimen Collection ** Non-Polio AFP Rate < >2 No Non-Polio AFP Case Total AFP Cases = 237 Non-Polio AFP Rate = 1.87 Adequate Stool specimen = 80% Provinces reporting AFP cases= 65 (84%) Adequate Stool Specimen Collection < 60% 60% 79% > 80% No AFP Case * Number of discarded AFP cases per 100,000 children under 15 years of age ** Percentage with 2 specimens 24 hours apart and within 14 days of paralysis onset. Note: Some AFP cases may still be pending final classification. 16

17 Non-polio AFP Cases by Month of Onset Thailand, Month Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec Total

18 # Cases # Deaths # Tested for serology # Measles +ve # Rubella +ve # Outbreaks # Outbreaks Investigated # Cases # Deaths # Outbreaks # Cases # Outbreaks # Cases # Outbreaks # Cases Neonatal Tetanus Diphtheria Pertussis Encephalitis Number of Cases of AEFI 2 Date of last report # reports expected % Completeness % Timeliness VPD Reporting, 2014 Routine Reporting of clinically suspected measles cases Suspected measles outbreaks Laboratory Confirmed 1 Number of Cases Country Measles Outbreaks Rubella Outbreaks Mixed Outbreaks Bangladesh NR Feb Bhutan Jan DPR Korea Mar India NR NR NR NR NR NR NR NR NR NR NR NR NR NR NR NR NR NR NR NR NR Indonesia NR NR NR 17-Feb Maldives Jan Myanmar Feb Nepal NR NR Feb Sri Lanka Feb Thailand NR 22-Jan Timor-Leste Jan Total At least 5 blood samples should be collected and tested from each outbreak. 2 Adverse Events Follow ing Immunization; Sri Lanka AEFI data do not reflect cases but events. 3 Monthly VPD and AEFI reports due to SEARO/IVD on or before 15th of each month. NR=No report Data as of 31 January 2015

19 # Cases # Deaths # Tested for serology # Measles +ve # Rubella +ve # Outbreaks # Outbreaks Investigated # Cases # Deaths # Outbreaks # Cases # Outbreaks # Cases # Outbreaks # Cases Neonatal Tetanus Diphtheria Pertussis Encephalitis Number of Cases of AEFI 2 Date of last report # reports expected % Completeness % Timeliness VPD Reporting, 2015 Routine Reporting of clinically suspected measles cases Suspected measles outbreaks Laboratory Confirmed 1 Number of Cases Country Measles Outbreaks Rubella Outbreaks Mixed Outbreaks Bangladesh NR Feb Bhutan NR NR NR NR NR NR NR NR NR NR NR NR NR NR NR NR NR NR NR NR NR DPR Korea NR NR NR NR NR NR NR NR NR NR NR NR NR NR NR NR NR NR NR NR NR India NR NR NR NR NR NR NR NR NR NR NR NR NR NR NR NR NR NR NR NR NR Indonesia Feb Maldives Feb Myanmar Feb Nepal Feb Sri Lanka Feb Thailand NR NR NR NR NR NR NR NR NR NR NR NR NR NR NR NR NR NR NR NR NR Timor-Leste NR NR NR NR NR NR NR NR NR NR NR NR NR NR NR NR NR NR NR NR NR Total At least 5 blood samples should be collected and tested from each outbreak. 2 Adverse Events Follow ing Immunization; Sri Lanka AEFI data do not reflect cases but events. 3 Monthly VPD and AEFI reports due to SEARO/IVD on or before 15th of each month. NR=No report Data as of 31 January 2015

20 Measles and Rubella Serology (IgM), 2014 # % # % Bangladesh Dhaka Bhutan Thimphu DPR Korea Pyongyang India India Total Indonesia Indonesia Total Ahmedabad Bengaluru Bhopal Chennai Guw ahati Hyderabad Jaipur Kolkata Lucknow Patna Pune Bandung Jakarta Surabaya Yogyakarta Maldives Male Myanmar Yangon Nepal Kathmandu Sri Lanka Colombo Thailand Bangkok Timor-Leste Dilli NR NR NR NR NR NR NR TOTAL Country Laboratories Source: Reported by SEAR Measles Laboratory Netw ork 1 To be reported w ithin 4 days in in transition state Number of Serum Samples Received Number Tested NR=No Report Measles +ve Results Rubella +ve % Results Reported w ithin 7 Days 1 Data as of 31 January 2015

21 Measles and Rubella Serology (IgM), 2015 # % # % Bangladesh Dhaka Bhutan Thimphu NR NR NR NR NR NR NR DPR Korea Pyongyang NR NR NR NR NR NR NR India Indonesia Indonesia Total Ahmedabad Bengaluru Bhopal NR Chennai Delhi Guw ahati Hyderabad Jaipur Kolkata Lucknow Patna Pune NR NR NR NR NR NR NR Bandung Jakarta Surabaya Yogyakarta Maldives Male Myanmar Yangon Nepal Kathmandu Sri Lanka Colombo Thailand Bangkok Timor-Leste Dilli NR NR NR NR NR NR NR TOTAL Country India Total Laboratories Source: Reported by SEAR Measles Laboratory Netw ork 1 To be reported w ithin 4 days from in transition state Number of Serum Samples Received Number Tested NR=No Report Measles +ve Results Rubella +ve % Measles Results Reported w ithin 4 Days 1 Data as of 31 January 2015

Monthly Vaccine Preventable Disease and Immunization Update Published: May 11, 2018 Immunization and Vaccine Development (IVD) SEARO

Monthly Vaccine Preventable Disease and Immunization Update Published: May 11, 2018 Immunization and Vaccine Development (IVD) SEARO Monthly Vaccine Preventable Disease and Immunization Update Published: May 11, 2018 Immunization and Vaccine Development (IVD) SEARO Protecting People from Vaccine Preventable Diseases Last wild poliovirus

More information

Immunization and Vaccine Development (IVD) SEARO

Immunization and Vaccine Development (IVD) SEARO Monthly Vaccine Preventable Disease and Immunization Update Published: January 03, 2018 Immunization and Vaccine Development (IVD) SEARO Protecting People from Vaccine Preventable Diseases Last wild poliovirus

More information

Immunization and Vaccine Development (IVD) SEARO

Immunization and Vaccine Development (IVD) SEARO VPD Update for Week 33, 2014 Data as of 18 August 2014 Immunization and Vaccine Development (IVD) SEARO Protecting People from Vaccine Preventable Diseases Last wild poliovirus case by type, SEAR WPV Type

More information

VPD Update for Week 1, 2018 Data as of 8 January 2018 Immunization and Vaccine Development (IVD) SEARO

VPD Update for Week 1, 2018 Data as of 8 January 2018 Immunization and Vaccine Development (IVD) SEARO VPD Update for Week 1, 2018 Data as of 8 January 2018 Immunization and Vaccine Development (IVD) SEARO Protecting People from Vaccine Preventable Diseases Last wild poliovirus cases confirmed by type,

More information

Measles and Rubella Fact Sheet SEAR #

Measles and Rubella Fact Sheet SEAR # and Fact Sheet SEAR 8-9 Table : South-East Asia Regional (SEAR) Strategic Plan 7- Goal: To reduce the number of measles deaths by 9 in relative to estimates. Objectives: Achieve at least 9 national Containing

More information

South-East Asia Regional Committee resolution (September 2013, New Delhi)

South-East Asia Regional Committee resolution (September 2013, New Delhi) South-East Asia Regional Committee resolution (September 2013, New Delhi) SEAR Member States adopted the goal of measles elimination and rubella/crs control in the South-East Asia Region by 2020. Achieving

More information

Total population 24,759,000. Live births (LB) 342,458. Children <1 year 337,950. Children <5 years 1,698,664. Children <15 years 5,233,093

Total population 24,759,000. Live births (LB) 342,458. Children <1 year 337,950. Children <5 years 1,698,664. Children <15 years 5,233,093 DPR Korea 4 Immunization system highlights There is a comprehensive multiyear plan (cmyp) for immunization covering -5. A standing national technical advisory group on immunization (NTAGI) with formal

More information

Total population 1,212,110. Live births (LB) 43,924. Children <1 year 40,351. Children <5 years 192,340. Children <15 years 510,594

Total population 1,212,110. Live births (LB) 43,924. Children <1 year 40,351. Children <5 years 192,340. Children <15 years 510,594 Draft version for the SEAR-ITAG 5-9 June 5 All data provisional as of May 5 Timor Leste 4 Immunization system highlights There is a comprehensive multi-year plan (cmyp) for immunization covering 3-5. 8%

More information

Total population 20,675,000. Live births (LB) 349,715. Children <1 year 346,253. Children <5 years 1,778,050. Children <15 years 5,210,100

Total population 20,675,000. Live births (LB) 349,715. Children <1 year 346,253. Children <5 years 1,778,050. Children <15 years 5,210,100 Sri Lanka 4 Immunization system highlights There is a comprehensive multi-year plan (cmyp) for immunization system strengthening covering -6. A national policy on immunization has been developed. A standing

More information

Total population 1,265,308,000. Live births (LB) 27,016,000. Children <1 year 25,928,200. Children <5 years 23,818,000. Children <15 years 25,639,000

Total population 1,265,308,000. Live births (LB) 27,016,000. Children <1 year 25,928,200. Children <5 years 23,818,000. Children <15 years 25,639,000 India 4 Immunization system highlights There is a comprehensive multiyear plan (cmyp) for immunization covering 3-7. National technical advisory group on immunization (NTAGI) exists and formal written

More information

Expanded Programme on Immunization (EPI)

Expanded Programme on Immunization (EPI) Timor-Leste 217 Expanded Programme on Immunization (EPI) FACT SHEET Acronyms AD Auto disable MCV1 First dose measles containing vaccine AEFI Adverse events following immunization MCV2 Second dose measles

More information

Expanded Programme on Immunization (EPI)

Expanded Programme on Immunization (EPI) Indonesia 217 Expanded Programme on Immunization (EPI) FACT SHEET Acronyms AD Auto disable MCV1 First dose measles containing vaccine AEFI Adverse events following immunization MCV2 Second dose measles

More information

Table 1: Basic information Total population 25,030, (per 100,000 LB) Division/Province/State/Region 11. District 210

Table 1: Basic information Total population 25,030, (per 100,000 LB) Division/Province/State/Region 11. District 210 EPI history EPI launched in 980 HepB vaccine introduced in 003 AD syringes introduced in 003 HepB birth dose introduced in 004 DTP-HepB vaccine introduced in 006 MCV introduced in 008 DTP-Hib-HepB vaccine

More information

Table 1: Basic information (per 1,000 LB) 42.4 (per 1,000 LB) 49.7 (per 1,000 LB) 215 (per 100,000 LB)

Table 1: Basic information (per 1,000 LB) 42.4 (per 1,000 LB) 49.7 (per 1,000 LB) 215 (per 100,000 LB) EPI history EPI started in 978 EPI re-structured in March 000 DTP-HepB vaccine introduced in 007 DTP-Hib-HepB)vaccine introduced in 0 MR vaccine introduced in Feb 06 Second dose of MR introduced in Feb

More information

Update on Polio Eradication in the World Health Organization South-East Asia Region, 2013

Update on Polio Eradication in the World Health Organization South-East Asia Region, 2013 SUPPLEMENT ARTICLE Update on Polio Eradication in the World Health Organization South-East Asia Region, 2013 Patrick Michael O Connor, 1 Robert Allison, 1 Arun Thapa, 1 Sunil Bahl, 2 Supamit Chunsuittiwat,

More information

Expanded Programme on Immunization (EPI)

Expanded Programme on Immunization (EPI) Sri Lanka 217 Expanded Programme on Immunization (EPI) FACT SHEET Acronyms AD Auto disable MCV1 First dose measles containing vaccine AEFI Adverse events following immunization MCV2 Second dose measles

More information

Table 1: Basic information 2017

Table 1: Basic information 2017 EPI history EPI launched in 978 OPV and MCV introduced in 987 AD syringes introduced in 00 HepB vaccine introduced in 003 MCV introduced partially in 008 and made available nationwide in 0 DTP-Hib-HepB

More information

Table 1: Basic information ,000, (per 1,000 LB) 34.6 (per 1,000 LB) 174 (per 100,000 LB) District 712.

Table 1: Basic information ,000, (per 1,000 LB) 34.6 (per 1,000 LB) 174 (per 100,000 LB) District 712. EPI history EPI launched in 978 with DPT, OPV, BCG and typhoid vaccines TT immunization of pregnant women introduced in 983 MCV introduced in 985 HepB piloted in 00 and made universal in 0 MCV introduced

More information

Draft Programme (05 May 2016)

Draft Programme (05 May 2016) Innovations in sustainable Draft Programme (05 May 2016) Draft 7 th Meeting of the South-East Asia Region Immunization Technical Advisory Group (SEAR ITAG) 6-10 June 2016, New Delhi (India) Day 1, Monday,

More information

Global Measles and Rubella Update November 2018

Global Measles and Rubella Update November 2018 Global Measles and Rubella Update November 218 Measles Number of Reported Measles by WHO Regions 218 Region Member States* Suspected cases Measles cases Clin Epi Lab Jan Feb Mar Apr May Jun Jul Aug Sep

More information

Global Measles and Rubella Update October 2018

Global Measles and Rubella Update October 2018 Global Measles and Rubella Update October 218 Measles Number of Reported Measles Cases by WHO Regions 218 Region Member States* Suspected cases Measles cases Clin Epi Lab Jan Feb Mar Apr May Jun Jul Aug

More information

Global Measles and Rubella Update. April 2018

Global Measles and Rubella Update. April 2018 Global Measles and Rubella Update April 218 Measles Number of Reported Measles by WHO Regions 218 Region Member States* Suspected cases Measles cases Clin Epi Lab Jan Feb Mar Apr May Jun Jul Aug Sep Oct

More information

Reduction of child and maternal mortality in South-East Asia Region WHO-SEARO. UNESCAP Forum, New Delhi: 17 Feb 2012

Reduction of child and maternal mortality in South-East Asia Region WHO-SEARO. UNESCAP Forum, New Delhi: 17 Feb 2012 Reduction of child and maternal mortality in South-East Asia Region WHO-SEARO 1 1 Progress in MDG 4 in SEAR Country Under 5 Mortality 2010 Target U5MR MDG 4 Status MDG4: Reduction of U5MR by two thirds

More information

Expanded Programme on Immunization (EPI)

Expanded Programme on Immunization (EPI) Bhutan 2017 Expanded Programme on Immunization (EPI) FACT SHEET Acronyms AD Auto disable MCV1 First dose measles containing vaccine AEFI Adverse events following immunization MCV2 Second dose measles containing

More information

Progress towards achieving Millennium Development Goal 5 in South-East Asia

Progress towards achieving Millennium Development Goal 5 in South-East Asia DOI:.1111/j.1471-528.211.38.x www.bjog.org Commentary Progress towards achieving Millennium Development Goal 5 in South-East Asia M Islam Family Health and Research, World Health Organisation, South East

More information

IEAG Findings 5-6 December 2005

IEAG Findings 5-6 December 2005 IEAG Findings 5-6 December 005 Surveillance Quality Surveillance Indicators India 005* 5.47 8% Less than 60% 60% to 69% 70% to 79% 80% and above No AFP case * data as on 6th November 005 AFP cases India

More information

Wild Poliovirus*, 03 Aug 2004 to 02 Aug 2005

Wild Poliovirus*, 03 Aug 2004 to 02 Aug 2005 Wild Poliovirus*, 03 Aug 2004 to 02 Aug 2005 Wild virus type 1 Wild virus type 3 Wild virus type 1 & 3 Endemic countries Re-established transmission countries Case or outbreak following importation *Excludes

More information

Programmatic Feasibility of Measles Elimination in South East Asia Region

Programmatic Feasibility of Measles Elimination in South East Asia Region Programmatic Feasibility of Elimination in South East Asia Region A. Introduction: In 2005, World Health Assembly resolution WHA58.15 endorsed the Global Immunization Vision and Strategies (GIVS) that

More information

Eighth Meeting of the International Certification Commission for Polio Eradication for the South-East Asia Region

Eighth Meeting of the International Certification Commission for Polio Eradication for the South-East Asia Region SEA-Polio-45 Distribution: General Eighth Meeting of the International Certification Commission for Polio Eradication for the South-East Asia Region The Report 13-15 September 2006, New Delhi, India Regional

More information

Status of Outbreak Vulnerable Countries

Status of Outbreak Vulnerable Countries Status of Outbreak Vulnerable Countries Hamid Jafari, WHO Robert Linkins, CDC Independent Monitoring Board Meeting 7-8 May, 2013 Outline Non-Endemic Vulnerable & At-Risk Countries Recently infected countries

More information

HIV Drug Resistance Surveillance and Monitoring in the Southeast Asia Region

HIV Drug Resistance Surveillance and Monitoring in the Southeast Asia Region HIV Drug Resistance Surveillance and Monitoring in the Southeast Asia Region Padmini Srikantiah, MD MPH HIV/AIDS Unit WHO- Regional Office for Southeast Asia The HIV epidemic in Southeast Asia Estimated

More information

HIV Situation in South-East Asia. HIV unit Department of Communicable Diseases

HIV Situation in South-East Asia. HIV unit Department of Communicable Diseases HIV Situation in South-East Asia HIV unit Department of Communicable Diseases Outline Magnitude of HIV burden in South-East Asia Progress towards MDGs Regional success stories Issues and concerns Summary

More information

宮村参考人提出資料 資料 2-2

宮村参考人提出資料 資料 2-2 宮村参考人提出資料 資料 - Highlights of New Wild Poliovirus and cvdpv Positives Reported Globally this Week WPV cvdpv AFP other AFP other Afghanistan 5 Pakistan 3 Nigeria Location: state/province/governorate Kunar

More information

First South-East Asia Regional Technical Advisory Group on Immunization (SEAR ITAG) Meeting

First South-East Asia Regional Technical Advisory Group on Immunization (SEAR ITAG) Meeting SEA-Immun-17 Distribution: Limited First South-East Asia Regional Technical Advisory Group on Immunization (SEAR ITAG) Meeting A Brief Report 14 15 July 2008, Bangkok, Thailand Regional Office for South-East

More information

VPD in Mediterranean Basin and Black Sea: the Polio case

VPD in Mediterranean Basin and Black Sea: the Polio case Screening practices for infectious diseases among newly arrived migrants and Vaccine Preventable Disease (VPD): strategies and coverage ISS 29 MAY 2015 VPD in Mediterranean Basin and Black Sea: the Polio

More information

REPORT Of the FIRST SOUTH-EAST ASIA REGIONAL TECHNICAL ADVISORY GROUP ON IMMUNIZATION (SEAR ITAG) MEETING July 2008 Bangkok, Thailand

REPORT Of the FIRST SOUTH-EAST ASIA REGIONAL TECHNICAL ADVISORY GROUP ON IMMUNIZATION (SEAR ITAG) MEETING July 2008 Bangkok, Thailand 1 REPORT Of the FIRST SOUTH-EAST ASIA REGIONAL TECHNICAL ADVISORY GROUP ON IMMUNIZATION (SEAR ITAG) MEETING 14-15 July 2008 Bangkok, Thailand 2 First South-East Asia Regional Technical Advisory Group on

More information

International Commission for the Certification of Poliomyelitis Eradication in the South-East Asia Region

International Commission for the Certification of Poliomyelitis Eradication in the South-East Asia Region SEA-Polio-24 Distribution: General International Commission for the Certification of Poliomyelitis Eradication in the South-East Asia Region Report of the Fourth Meeting New Delhi, 21 23 March 2001 WHO

More information

STATUS OF EAR AND HEARING CARE IN SOUTH EAST ASIA REGION

STATUS OF EAR AND HEARING CARE IN SOUTH EAST ASIA REGION STATUS OF EAR AND HEARING CARE IN SOUTH EAST ASIA REGION Dr. Suneela Garg Director Professor, Department of Community Medicine, Maulana Azad Medical College, New Delhi, India Director - Society for Sound

More information

Polio endgame strategy The challenges for Asia Pacific Region

Polio endgame strategy The challenges for Asia Pacific Region Polio endgame strategy The challenges for Asia Pacific Region Vaccinology 2013 1 st International Symposium for Asia Pacific Experts Bangkok, Thailand November 11-14 th, 2013 May Book-Montellano, MD >

More information

Polio Eradication and Surveillance. December

Polio Eradication and Surveillance. December Polio Eradication and Surveillance December 2017 1 Acute Flaccid Paralysis (AFP) surveillance for polio eradication: >100,000 reported AFP per year December 2017 2 Global Laboratory Network for Polio Eradication

More information

Polio Eradication in India. Dr Sunil Bahl Deputy Project Manager WHO Country Office for India 28 October 2014

Polio Eradication in India. Dr Sunil Bahl Deputy Project Manager WHO Country Office for India 28 October 2014 Polio Eradication in India Dr Sunil Bahl Deputy Project Manager WHO Country Office for India 28 October 2014 History of Polio in India Number of Cases 200,000 200,000 OPV Introduced in RI - 1978 150,000

More information

All photographs used on the cover page are from WHO sources.

All photographs used on the cover page are from WHO sources. WHO Library Cataloguing-in-Publication data World Health Organization, Regional Office for South-East Asia. Achieving the health-related Millennium Development Goals in the South-East Asia region: Measuring

More information

Poliovirus : éradication pour les prochaines JNI?

Poliovirus : éradication pour les prochaines JNI? Poliovirus : éradication pour les prochaines JNI? Bruno LINA CNR des entérovirus Laboratoire de virologie EST, GHE, HCL FRE 3011 CNRS UCBL, Lyon Polio Eradication Initiative 1 Polio Eradication Progress

More information

TB in the SEA Region. Review Plans and Progress. Dr Md Khurshid Alam Hyder Medical Officer TB SEARO/WHO

TB in the SEA Region. Review Plans and Progress. Dr Md Khurshid Alam Hyder Medical Officer TB SEARO/WHO TB in the SEA Region Review Plans and Progress Dr Md Khurshid Alam Hyder Medical Officer TB SEARO/WHO The SEA Region: 25% of the world s people, but >33% of TB patients Eastern M editerranean Region 5%

More information

Polio eradication. Report of the Sixth Meeting of the South-East Asia Regional Certification Commission (SEA-RCCPE) Kathmandu, November 2013

Polio eradication. Report of the Sixth Meeting of the South-East Asia Regional Certification Commission (SEA-RCCPE) Kathmandu, November 2013 SEA-Immun-84 Distribution: General Polio eradication Report of the Sixth Meeting of the South-East Asia Regional Certification Commission (SEA-RCCPE) Kathmandu, 25 27 November 2013 World Health Organization

More information

Protecting people from Vaccine Preventable Diseases

Protecting people from Vaccine Preventable Diseases Protecting people from Vaccine Preventable Diseases Immunization and Vaccine Development South East Asia Region Strategic Plan (2010 2013) Table of Contents INTRODUCTION...2 1. THE IVD MISSION IN THE GLOBAL

More information

Enterovirus Research Centre Mumbai. Highlights of work done

Enterovirus Research Centre Mumbai. Highlights of work done Enterovirus Research Centre Mumbai Highlights of work done -07 was the most difficult year experienced by the Enterovirus Research Centre. In the early morning hours on 21 st April, fire broke out in the

More information

International Commission for the Certification of Poliomyelitis Eradication in the South-East Asia

International Commission for the Certification of Poliomyelitis Eradication in the South-East Asia SEA-Polio-30 Distribution: General International Commission for the Certification of Poliomyelitis Eradication in the South-East Asia Report of the Fifth Meeting New Delhi, India, 5-8 March 2001 WHO Project:

More information

Polio Eradication: Beginning of the End, or End of the Beginning?

Polio Eradication: Beginning of the End, or End of the Beginning? Polio Eradication: Beginning of the End, or End of the Beginning? University of Colorado Jon Kim Andrus, MD Adjoint Professor and Director Vaccines and Immunization Center for Global Health University

More information

Global and Regional update on Polio Eradication Activities. Kenya Paediatric Association Pride Inn, Mombasa April 26, 2018

Global and Regional update on Polio Eradication Activities. Kenya Paediatric Association Pride Inn, Mombasa April 26, 2018 Global and Regional update on Polio Eradication Activities Kenya Paediatric Association Pride Inn, Mombasa April 26, 2018 Presentation Outline 1. Background information 2. Poliovirus detection & interruption

More information

Highlighting in the WHO European Region: Summary. No. 21(February 2012)

Highlighting in the WHO European Region: Summary. No. 21(February 2012) No. 21(February 2012) Issue 15, April 2011 A monthly publication on vaccine preventable diseases and immunization data and analysis Highlighting in the WHO European Region: Update on measles in the European

More information

Progress reports on selected Regional Committee resolutions:

Progress reports on selected Regional Committee resolutions: REGIONAL COMMITTEE Provisional Agenda item 4.7.2 Sixty-sixth Session SEA/RC66/14 SEARO, New Delhi, India 10 13 September 2013 19 July 2013 Progress reports on selected Regional Committee resolutions: 2012:

More information

REGIONAL COMMITTEE Provisional Agenda item 5.3. SEA/RC64/8 Inf. Doc. Jaipur, Rajasthan, India 6 9 September August 2011

REGIONAL COMMITTEE Provisional Agenda item 5.3. SEA/RC64/8 Inf. Doc. Jaipur, Rajasthan, India 6 9 September August 2011 REGIONAL COMMITTEE Provisional Agenda item 5.3 Sixty-fourth Session SEA/RC64/8 Inf. Doc. Jaipur, Rajasthan, India 6 9 September 2011 2 August 2011 The attached document provides detailed and supplementary

More information

Quality Assurance in HIV Testing

Quality Assurance in HIV Testing SEA-HLM-378 Distribution: General Quality Assurance in HIV Testing Report of a Regional Workshop Pune, India, 24-28 November 2003 WHO Project: ICP BCT 001 World Health Organization Regional Office for

More information

POLIO ERADICATION AND POST-CERTIFICATION STRATEGY

POLIO ERADICATION AND POST-CERTIFICATION STRATEGY POLIO ERADICATION AND POST-CERTIFICATION STRATEGY PRE-BOARD MEETING 5 June 2018, Geneva Reach every child www.gavi.org Agenda Topic Presenter 1. Polio eradication update WHO 10 minutes 2. IPV supply, demand

More information

CDC ASSESSMENT OF RISKS TO THE GLOBAL POLIO ERADICATION INITIATIVE (GPEI) STRATEGIC PLAN

CDC ASSESSMENT OF RISKS TO THE GLOBAL POLIO ERADICATION INITIATIVE (GPEI) STRATEGIC PLAN CDC ASSESSMENT OF RISKS TO THE GLOBAL POLIO ERADICATION INITIATIVE (GPEI) STRATEGIC PLAN 2010-2012 14 Sept-10 2010 First and Second Quarters (January June) Geographic distribution of wild poliovirus (WPV)

More information

Table 1. Measles case classification and incidence by country and area, WHO Western Pacific Region,

Table 1. Measles case classification and incidence by country and area, WHO Western Pacific Region, Volume 7 Issue 5 May 2013 ISSN 1814 3601 Table 1. case classification and by country and area, WHO Western Pacific Region, 2008 2013 1 confirmed 2 2 009 per confirmed 2 2 010 2 011 2 012 2013 1 Confirmed

More information

The Switch From Trivalent to Bivalent Oral Poliovirus Vaccine in the South-East Asia Region

The Switch From Trivalent to Bivalent Oral Poliovirus Vaccine in the South-East Asia Region The Journal of Infectious Diseases SUPPLEMENT ARTICLE The Switch From Trivalent to Bivalent Oral Poliovirus Vaccine in the South-East Asia Region Sunil Bahl, 1 Andreas Hasman, 2 Abu Obeida Eltayeb, 3 Douglas

More information

Global and National Trends in Vaccine Preventable Diseases. Dr Brenda Corcoran National Immunisation Office.

Global and National Trends in Vaccine Preventable Diseases. Dr Brenda Corcoran National Immunisation Office. Global and National Trends in Vaccine Preventable Diseases Dr Brenda Corcoran National Immunisation Office Global mortality 2008 Children under 5 years of age 1.5 million deaths due to vaccine preventable

More information

Current situation and capacity in the South-East Asia Region

Current situation and capacity in the South-East Asia Region Current situation and capacity in the South-East Asia Region Theme: Diabetes / Obesity Chandrika N Wijeyaratne Sri Lanka Medical Association TWG on Regional Action Plan on NCD Bangkok June 2013 INDICATORS

More information

Global Overview Polio Partners Group, December Note: Gavi requirements of $122.2 million are not included in this slide

Global Overview Polio Partners Group, December Note: Gavi requirements of $122.2 million are not included in this slide Global Overview Polio Partners Group, December 2015 1 Note: Gavi requirements of $122.2 million are not included in this slide The Polio Endgame Plan 1. Poliovirus detection & interruption 2. OPV2 withdrawal,

More information

Remarkable progress, new horizons and renewed commitment. Ending preventable maternal, newborn and child deaths in South-East Asia Region

Remarkable progress, new horizons and renewed commitment. Ending preventable maternal, newborn and child deaths in South-East Asia Region Remarkable progress, new horizons and renewed commitment Ending preventable maternal, newborn and child deaths in South-East Asia Region i ii Foreword MDGs 4 and 5 inspired unprecedented efforts by countries

More information

Hypertension in the South-East Asia Region: an overview

Hypertension in the South-East Asia Region: an overview Hypertension in the South-East Asia Region: an overview Anand Krishnan i, Renu Garg ii and Athula Kahandaliyanage iii Abstract Raised blood pressure or hypertension is the single most important risk factor

More information

Report of the Regional Consultation on Measles

Report of the Regional Consultation on Measles Report of the Regional Consultation on Measles SEARO, New Delhi, India, 25 27 August 2009 Regional Office for South-East Asia SEA-Immun-57 Distribution: General Report of the Regional Consultation on

More information

Polio Eradication in the World Health Organization South-East Asia Region by the Year 2000: Midway Assessment of Progress and Future Challenges

Polio Eradication in the World Health Organization South-East Asia Region by the Year 2000: Midway Assessment of Progress and Future Challenges S89 Polio Eradication in the World Health Organization South-East Asia Region by the Year 2000: Midway Assessment of Progress and Future Challenges Jon K. Andrus, Kaushik Banerjee, Barbara P. Hull, Jean

More information

Update on Status of Wild Poliovirus Outbreak in Kenya. 9 th Meeting of the IMB 1-3 October 2013 London, UK

Update on Status of Wild Poliovirus Outbreak in Kenya. 9 th Meeting of the IMB 1-3 October 2013 London, UK Update on Status of Wild Poliovirus Outbreak in Kenya 9 th Meeting of the IMB 1-3 October 2013 London, UK Contents Background Confirmation and Immediate Response High Risk Areas Coordination of Response

More information

Pakistan & Afghanistan: Will we soon see the end of polio?

Pakistan & Afghanistan: Will we soon see the end of polio? Pakistan & Afghanistan: Will we soon see the end of polio? The view from the perspective of the Country Programs Christopher Maher Manager Polio Eradication WHO, EMRO PPG 5 December 2016 Current situation

More information

VII THE CHILDHOOD IMMUNISATION PROGRAMME IN SINGAPORE 7. 7

VII THE CHILDHOOD IMMUNISATION PROGRAMME IN SINGAPORE 7. 7 VII THE CHILDHOOD IMMUNISATION PROGRAMME IN SINGAPORE IMMUNISATION PROGRAMME IN 2002 7. 7 The childhood immunisation programme in Singapore offers vaccination against tuberculosis, hepatitis B, diphtheria,

More information

Ethics Perspective of Immunisation Programs

Ethics Perspective of Immunisation Programs Ethics Perspective of Immunisation Programs with special reference to Herd Effect T Jacob John Vellore, India Annecy 26 October 2010 Defining Herd immunity and Herd effect. Between participants and nonparticipants

More information

Global Polio Eradication & Endgame Strategy. December 2015

Global Polio Eradication & Endgame Strategy. December 2015 Global Polio Eradication & Endgame Strategy December 2015 Poliovirus detection & interruption OPV withdrawal, IPV introduction, RI strengthening Containment & Global Certification Legacy Planning Polio

More information

Highlighting in the WHO European Region:

Highlighting in the WHO European Region: No. 23(April 2012) Issue 15, April 2011 A monthly publication on vaccine preventable diseases and immunization data and analysis Highlighting in the WHO European Region: Update on measles in the European

More information

South-East Asia Regional Immunization Technical Advisory Group (SEAR-ITAG) Meeting Report

South-East Asia Regional Immunization Technical Advisory Group (SEAR-ITAG) Meeting Report The eighth meeting of the World Health Organization's South-East Asia Regional Immunization Technical Advisory Group (SEAR-ITAG) was held from 13 to 16 June 2017 in New Delhi, India. SEAR-ITAG is a technical

More information

Update on Progress and Challenges in Achieving Measles and Rubella Targets

Update on Progress and Challenges in Achieving Measles and Rubella Targets Update on Progress and Challenges in Achieving Measles and Rubella Targets SAGE Meeting 6 November 2013 P. Strebel, WHO/IVB/EPI Overview Global progress Regional updates Summary 2 Measles and Rubella Targets

More information

Joint National/International Review of Acute Flaccid Paralysis (AFP) Surveillance Nepal

Joint National/International Review of Acute Flaccid Paralysis (AFP) Surveillance Nepal SEA Polio 44 Distribution: Limited Joint National/International Review of Acute Flaccid Paralysis (AFP) Surveillance Nepal 25 March 6 April 2006 and 6-12 August 2006 World Health Organization This document

More information

Programme Update. Transition Independent Monitoring Board London, 2 November Geneva, 23 October 2017

Programme Update. Transition Independent Monitoring Board London, 2 November Geneva, 23 October 2017 Programme Update Transition Independent Monitoring Board London, 2 November 2017 On Behalf of GPEI - Michel Zaffran, Director Polio Eradication, WHO Geneva, 23 October 2017 1 Polio Eradication and Endgame

More information

Millennium Development Goals in the South-East Asia Region: Measuring Indicators

Millennium Development Goals in the South-East Asia Region: Measuring Indicators World Health House Indraprastha Estate, Mahatma Gandhi Marg, New Delhi-110002, India Web site: www.searo.who.int Member States of the World Health Organization (WHO) South-East Asia Region have made considerable

More information

South-East Asia Regional Certification Commission for Polio Eradication (SEA-RCCPE)

South-East Asia Regional Certification Commission for Polio Eradication (SEA-RCCPE) SEA-Immun-107 Distribution: General South-East Asia Regional Certification Commission for Polio Eradication (SEA-RCCPE) Report of the Eighth Meeting Bali, Indonesia, 22 24 September 2015 World Health Organization

More information

Global Polio Eradication, Progress, Impact of Ebola, Risks & Opportunities. Polio Partners Group 8 December 2014

Global Polio Eradication, Progress, Impact of Ebola, Risks & Opportunities. Polio Partners Group 8 December 2014 Global Polio Eradication, Progress, Impact of Ebola, Risks & Opportunities Polio Partners Group 8 December 2014 Outline Progress Impact of Ebola Priorities Risks Wild Poliovirus type 1 (WPV1) Cases, 2013

More information

Polio: A Global Update. DCVMN-- Seoul, Korea Simona Zipursky, WHO/HQ/POL September

Polio: A Global Update. DCVMN-- Seoul, Korea Simona Zipursky, WHO/HQ/POL September Polio: A Global Update DCVMN-- Seoul, Korea Simona Zipursky, WHO/HQ/POL September 27. 2017 1 Polio Eradication and Endgame Strategy 1. Poliovirus detection & interruption 2. OPV2 withdrawal, IPV introduction,

More information

Progress in maternal and child health: Uzbekistan and WHO European Region

Progress in maternal and child health: Uzbekistan and WHO European Region Progress in maternal and child health: Uzbekistan and WHO European Region The National Model of Maternal and Child Health Protection in Uzbekistan: Zsuzsanna Jakab WHO Regional Director for Europe UZBEKISTAN

More information

Second Meeting of the South-East Asia Regional Verification Commission for Measles Elimination and Rubella/Congenital Rubella Syndrome Control

Second Meeting of the South-East Asia Regional Verification Commission for Measles Elimination and Rubella/Congenital Rubella Syndrome Control SEA-Immun-113 Distribution: General Second Meeting of the South-East Asia Regional Verification Commission for Measles Elimination and Rubella/Congenital Rubella Syndrome Control Colombo, Sri Lanka, 18

More information

Progress reports on selected Regional Committee resolutions

Progress reports on selected Regional Committee resolutions REGIONAL COMMITTEE Provisional Agenda item 9 Seventy-first Session SEA/RC71/13 Rev.1 New Delhi, India 3 7 September 2018 21 August 2018 Progress reports on selected Regional Committee resolutions Progress

More information

Analysis of 3-dose oral/inactivated poliovirus vaccine (OPV3/IPV3) immunization coverage

Analysis of 3-dose oral/inactivated poliovirus vaccine (OPV3/IPV3) immunization coverage A MONTHLY NEWSLETTER OF THE COMMUNICABLE DISEASE UNIT, WORLD HEALTH ORGANIZATION REGIONAL OFFICE FOR EUROPE, COPENHAGEN, DENMARK Issue 5, March 2009 Analysis of 3-dose oral/inactivated poliovirus vaccine

More information

AI surveillance of domestic birds in Vietnam. Under the OIE/Japan Trust Fund Project (JTF) for Strengthening HPAI Control in Asia,

AI surveillance of domestic birds in Vietnam. Under the OIE/Japan Trust Fund Project (JTF) for Strengthening HPAI Control in Asia, AI surveillance of domestic birds in Vietnam Under the OIE/Japan Trust Fund Project (JTF) for Strengthening HPAI Control in Asia, 2008-2012 Kenji Sakurai, OIE Asia-Pacific Tokyo, 13-14 December 2012 Contents

More information

SEA-Immun-105 Distribution: General. WHO South-East Asia Regional Immunization Technical Advisory Group (SEAR-ITAG)

SEA-Immun-105 Distribution: General. WHO South-East Asia Regional Immunization Technical Advisory Group (SEAR-ITAG) SEA-Immun-105 Distribution: General WHO South-East Asia Regional Immunization Technical Advisory Group (SEAR-ITAG) Report of the Seventh Meeting of SEAR-ITAG New Delhi, India, 7 10 June 2016 World Health

More information

INTERNATIONAL CERTIFICATION COMMISSION FOR POLIO ERADICATION IN THE SOUTH-EAST ASIA REGION PLAN OF ACTION

INTERNATIONAL CERTIFICATION COMMISSION FOR POLIO ERADICATION IN THE SOUTH-EAST ASIA REGION PLAN OF ACTION WORLD HEALTH ORGANIZATION Regional Office for South-East Asia New Delhi SEA/Polio/11 12 February 1998 RESTRICTED INTERNATIONAL CERTIFICATION COMMISSION FOR POLIO ERADICATION IN THE SOUTH-EAST ASIA REGION

More information

UIP FACT SHEET. Socio - demographic profile PRL. Infant Mortality Rate

UIP FACT SHEET. Socio - demographic profile PRL. Infant Mortality Rate UIP FACT SHEET WEST BENGAL Census 1 Total Population 8,176,197 Population--6yr 11,414,222 Literacy Rate 68.6 Sex Ratio 934 Sex Ratio -6 yr 96 Socio - demographic profile Census 11 91,347,736 1,112,599

More information

SEA-TB-315 Distribution: General. Tuberculosis. in the South-East Asia Region

SEA-TB-315 Distribution: General. Tuberculosis. in the South-East Asia Region SEA-TB-315 Distribution: General Tuberculosis in the South-East Asia Region Annual Report: 29 World Health Organization 29 All rights reserved. Requests for publications, or for permission to reproduce

More information

FMD Control Initiatives in Bangladesh

FMD Control Initiatives in Bangladesh FMD Control Initiatives in Bangladesh Dr. Md. Mohsin Ali Dr. Md. Ainul Haque Department of Livestock Services, Bangladesh Country Profile In Short Bangladesh is a Republic of South Asia It is bordered

More information

TB-HIV in the South-East Asia Region

TB-HIV in the South-East Asia Region TB-HIV in the South-East Asia Region 13 th Core Group Meeting of the TB/HIV Working Group April 17-18 New York, USA Dr Nani Nair Regional Advisor-TB TB and HIV in South-East Asia Outline Epidemiology of

More information

Durham Region Influenza Bulletin: 2017/18 Influenza Season

Durham Region Influenza Bulletin: 2017/18 Influenza Season Durham Region Influenza Bulletin: 2017/18 Influenza Season Surveillance Week 21 (May 20, 2018 to May 26, 2018) Table 1: Assessment of influenza activity in Durham Region Measure Laboratory confirmed cases

More information

AIDA M. SALONGA, MD, FPNA, FCNSP CHAIR, AFP EXPERT PANEL, DOH MEMBER, REGIONAL CERTIFICATION COMMITTEE, WHO

AIDA M. SALONGA, MD, FPNA, FCNSP CHAIR, AFP EXPERT PANEL, DOH MEMBER, REGIONAL CERTIFICATION COMMITTEE, WHO POLIO FAQs on ENDGAME Tuberculosis AIDA M. SALONGA, MD, FPNA, FCNSP CHAIR, AFP EXPERT PANEL, DOH MEMBER, REGIONAL CERTIFICATION COMMITTEE, WHO OBJECTIVES Brief history of poliomyelitis Polio eradication:

More information

Measles: United States, January 1 through June 10, 2011

Measles: United States, January 1 through June 10, 2011 Measles: United States, January 1 through June 10, 2011 Preeta K. Kutty, MD, MPH Measles, Mumps, Rubella and Polio Team Division of Viral Diseases Centers for Disease Control and Prevention Atlanta, GA

More information

Elimination of Iodine Deficiency Disorders in South-East Asia

Elimination of Iodine Deficiency Disorders in South-East Asia SEA-NUT-174 Distribution: General Elimination of Iodine Deficiency Disorders in South-East Asia Report of an expert consultative meeting Bangkok, Thailand, 25 26 June 2007 Supplemented with Recommendations

More information

Regional Workshop for Strengthening Capacity and Internal Quality Assurance for the SEAR Measles and Rubella Laboratory Network

Regional Workshop for Strengthening Capacity and Internal Quality Assurance for the SEAR Measles and Rubella Laboratory Network In order to achieve the goal of measles elimination and rubella control by 2020, case-based measles surveillance activities in all countries of South-East Asia Region, World Health Organization, have gained

More information

Measles & rubella outbreaks in Maharashtra State, India

Measles & rubella outbreaks in Maharashtra State, India Indian J Med Res 143, February 2016, pp 227-231 DOI:10.4103/0971-5916.180214 Measles & rubella outbreaks in Maharashtra State, India Sunil R. Vaidya, Madhukar B. Kamble, Deepika T. Chowdhury & Neelakshi

More information

WHO VACCINE SUPPLY & QUALITY SUPPORT FOR NATIONAL IMMUNIZATION PROGRAMMES

WHO VACCINE SUPPLY & QUALITY SUPPORT FOR NATIONAL IMMUNIZATION PROGRAMMES WHO VACCINE SUPPLY & QUALITY SUPPORT FOR NATIONAL IMMUNIZATION PROGRAMMES Immunization and vaccine development in the last decade Since the Millennium Summit in 2000, immunization substantial international

More information

SOUTH-EAST ASIA ACTION PLAN

SOUTH-EAST ASIA ACTION PLAN SOUTHEAST ASIA ACTION PLAN 20162020 Cover Photos by: Ist Row: Ministry of Public Health Democratic People s Republic of Korea WHO/Bangladesh/R Kumar WHO/Bhutan WHO/India/R Kumar IInd Row: Ministry of Health/Epidemiology

More information

Getting to Zero: On the Verge of Polio Eradication. Ellyn Ogden, MPH USAID Worldwide Polio Eradication Coordinator May 17, 2017

Getting to Zero: On the Verge of Polio Eradication. Ellyn Ogden, MPH USAID Worldwide Polio Eradication Coordinator May 17, 2017 Getting to Zero: On the Verge of Polio Eradication Ellyn Ogden, MPH USAID Worldwide Polio Eradication Coordinator May 17, 2017 Polio Eradication and Endgame Strategy 1. Poliovirus detection & interruption

More information